Image de couverture de livre

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	Anees Bahji
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Addiction
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Response to Crockford et al .: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series
par: Nathaniel Day, et autres
Publié: (2026)

Post‐legalization shifts in cannabis use among young adults in Georgia—A nationally representative study
par: Ilia Nadareishvili, et autres
Publié: (2024)

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series
par: Nathaniel Day, et autres
Publié: (2026)

The psychometric properties of validated tools to assess cannabis use disorder: A systematic review and meta‐analysis
par: Janni Leung, et autres
Publié: (2026)

Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers
par: Jacob T. Borodovsky, et autres
Publié: (2024)

Estimating and comparing the effects of price‐ and potency‐based taxes on cannabis purchase patterns in an experimental cannabis marketplace
par: Jin Xing, et autres
Publié: (2025)

Prevalence of cannabis consumption methods among people with medically recommended and nonmedical cannabis use in the United States
par: Beth Han, et autres
Publié: (2025)

Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization
par: Laurent Perrault‐Sequeira, et autres
Publié: (2025)

Cross‐sectional and longitudinal associations of cannabis use with cognitive functioning in individuals with a cannabis use disorder: The moderating role of nicotine
par: Emese Kroon, et autres
Publié: (2026)

The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019
par: Seema Choksy Pessar, et autres
Publié: (2024)

A systematic review and meta‐analysis of self‐reported exposure to cannabis advertising and its association with cannabis use and intentions
par: Caitlin McClure‐Thomas, et autres
Publié: (2026)

Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California
par: Kelly C. Young‐Wolff, et autres
Publié: (2024)

The evolution of Australian cannabis policies, 1967 to 2024
par: Wayne D. Hall, et autres
Publié: (2026)

Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents
par: Renata Basso Cupertino, et autres
Publié: (2025)

Commentary on Pessar et al .: ‘Downscaling’ United States state cannabis policy to investigate environmental and social impacts on cannabis use
par: Jeremy Mennis, et autres
Publié: (2024)

Does the total consumption model apply to cannabis use?
par: Thor Norström, et autres
Publié: (2026)

High potency cannabis flower use is associated with heavier consumption and risk for cannabis use disorder among young adults in California, United States
par: Michael S. Dunbar, et autres
Publié: (2025)

Associations between modes of cannabis use and cannabis use disorder: Evidence from the 2022 to 2023 United States National Survey on Drug Use and Health
par: Amrit Baral, et autres
Publié: (2026)

How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?
par: Emma Beard, et autres
Publié: (2025)

Is toke cheap? Correspondence between cannabis demand and purchase in the laboratory
par: Elizabeth R. Aston, et autres
Publié: (2026)

Varenicline for cannabis use disorder: A randomized controlled trial
par: Aimee L. McRae‐Clark, et autres
Publié: (2026)

Addictive and harmful vapes must never be sold as a consumer good
par: Becky Freeman, et autres
Publié: (2024)

Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent cannabis use
par: Sophie G. Coelho, et autres
Publié: (2025)

Understanding medical cannabis use internationally: Why definitions and context matter
par: Myfanwy Graham, et autres
Publié: (2025)

Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points
par: Erin A. McClure, et autres
Publié: (2025)

Player tracking in itself may not be enough for efficient reduction of gambling harm, but combined with a personal gambling license could provide new possibilities to tracking gambling‐related harm
par: Janne Nikkinen
Publié: (2024)

Direct gambling marketing, direct harm: A randomised experiment
par: Matthew Rockloff, et autres
Publié: (2026)

Redefining harm: The role of data integration in understanding gambling behaviour
par: Naomi Muggleton
Publié: (2024)

Commentary on Baltes‐Flueckiger et al.: Rethinking expectations and evidence in cannabis policy
par: Sharon R. Sznitman, et autres
Publié: (2025)

Change of substance‐related hospitalisation in adolescents after cannabis legalisation in Thailand in 2022
par: Sirada Puetpaiboon, et autres
Publié: (2026)

The relationship between cannabis and nicotine use: A systematic review and meta‐analysis
par: Tesfa Mekonen Yimer, et autres
Publié: (2024)

Banning cigarette filters in the United Kingdom: Time to correct misperceptions of harms
par: Katherine East, et autres
Publié: (2025)

Commentary on Getty et al .: Complementarity of harm reduction and contingency management
par: John M. Roll
Publié: (2026)

Trends in gamma‐hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024
par: Amy Peacock, et autres
Publié: (2026)

Self‐harm in individuals with substance use disorders: Predictive factors and risk model
par: Rongqin Yu, et autres
Publié: (2026)

Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)
par: Natalie S. Schöllner, et autres
Publié: (2025)

Commentary on Coelho et al .: Ecological momentary assessments may be key to the future of cannabis studies
par: Lucy Chester, et autres
Publié: (2025)

Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States
par: Vijay M. Tiyyala, et autres
Publié: (2026)

Commentary on Dobbie et al .: Preventing adolescent gambling‐related harm—Is a universal approach sufficient?
par: Jérémie Richard
Publié: (2026)

Determining the impact of cannabis use on tobacco cessation: Results from a prospective non‐randomized tobacco treatment trial
par: Erin A. McClure, et autres
Publié: (2026)